JESSICA VASQUEZ: Open Payments
NPI 1982204541 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,798 in 81 payments from 16 companies in 2025. Trend: 2023 $864 · 2024 $1,039 · 2025 $1,798
Food & beverage: $1,699Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $532 |
| Janssen Biotech, Inc. | 20 | $432 |
| Ardelyx, Inc. | 7 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
| Aimmune Therapeutics, Inc. | 3 | $80 |
| Lilly USA, LLC | 4 | $77 |
| Intercept Pharmaceuticals, Inc. | 3 | $73 |
| Madrigal Pharmaceuticals | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $64 |
| Ipsen Biopharmaceuticals, Inc | 2 | $61 |
Products named: TREMFYA, CREON, RINVOQ, LINZESS, IBSRELA, ENTYVIO, ZENPEP, OMVOH.
Industry payments across FL — which companies pay providers there.
